De-risk Drug Development with our 3D Proteome Technology

Identify off-targets underlying unexplained toxicity, validate your target and find binding sites with our in vivo, quantitative platform to increase confidence in your drug development process. 

We also offer an end-to-end workflow. Inquire at [email protected].